WILMINGTON, Del. & VANCOUVER, BC — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD) and AbCellera (Nasdaq: ABCL) announced a multi-year, multi-program partnership to discover, develop, and commercialize potentially first-in-class treatments for patients… Read More
BOTHELL, Wash.–(BUSINESS WIRE)– Seagen Inc. (Nasdaq:SGEN) (Seagen or the Company) reported financial results today for the third quarter ended September 30, 2023. David Epstein, Chief Executive Officer of Seagen said, “Seagen… Read More
Highly specialized talent appointed to lead RBCx’s early stage banking and life sciences segments, and deliver tailored capital, advice and scale-up solutions TORONTO, ON — RBCx, Royal Bank of Canada’s technology… Read More
‘Be the MVP’ campaign aims to change the odds on lung cancer in Canada KIRKLAND, QC – Hayley Wickenheiser and Merck Canada are teaming up to challenge all Canadians to… Read More
Topline data from the Phase III ALIGN study showed that Novartis’ investigational endothelin A receptor antagonist atrasentan met its primary endpoint, significantly reducing protein in the urine of patients with IgA nephropathy,… Read More
